
Towards Precision Cancer Therapy – From Biomarker Identification to Companion Diagnostic Assay Development
Xtalks Webinar Presentation
Anguraj Sadanandam, Ph.D. and colleagues at the Institute of Cancer Research have used NanoString® nCounter® technology to classify different gastrointestinal tumor types including colorectal cancer using gene signatures associated with cell-of-origin/phenotype, therapeutic response, and prognosis. Dr. Sadanandam will discuss the process of biomarker and companion diagnostic development including machine learning approaches in different gastrointestinal cancers and their translational relevance.